15 completed, 1 active not recruiting, 1 suspended, 1 terminated. 7 Not applicable, 6 Phase 3, 3 Phase 4, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Completed 5, Suspended 1, Withdrawn 1 |
| Phase 3 | 6 | Completed 5, Active not recruiting 1 |
| Phase 4 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 2 | Completed 2 |
Follow Diabetes, Type 2: new trials by email Literature Review of Diabetes, Type 2 trials Research Report on Diabetes, Type 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) PF-08653944, Placebo - Obesity, Overweight and/or Obesity | Phase 3 | Active not recruiting | Pfizer | 1078 | 2026-02-24 | 2026-10-13 |
| Calorie Restricted Dietary Intervention in Type 2 Diabetes Patients With Obesity for Remission Contrave ER, Low-calorie meal box - Diabetes, Type 2, Obesity &Amp; Overweight | Phase 4 | Completed | Yeouido St. Mary's Hospital | 25 | 2025-07-01 | 2026-08-07 |
| Comparative Effectiveness of Prescribed Adapted Physical Activity (APA), Either Practiced Independently After Training, or Supervised by an APA Teacher, on Glycemic Regulation in People With Unbalanced Type 2 Diabetes. adapted physical activity - Diabetes, Type 2, Non-Insulin Dependent | Not applicable | Suspended | Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète | 120 | 2025-02-24 | 2026-05-15 |
| A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes Insulin icodec, Insulin glargine - Diabetes, Type 2 | Phase 3 | Completed | Novo Nordisk A/S | 412 | 2024-04-19 | 2026-08-11 |
| The Study to Investigate the Contribution of Basal and Postprandial Glucose to Overall Hyperglycemia in T2DM Diabetes, Type 2 | Completed | West China Hospital | 337 | 2015-11-30 | 2020-02-11 | |
| The Inova Type 2 Diabetes Mellitus Study Glargine, NPH - Diabetes, Type 2 | Not applicable | Withdrawn | Inova Health Care Services | 2015-04-01 | 2016-08-05 | |
| A Lifestyle Intervention for Type 2 Diabetes Patients in Kuwait and Its Impact on Glycaemic Control Lifestyle intervention - Diabetes Mellitus, Noninsulin-Dependent, Diabetes, Type 2 | Not applicable | Completed | University of Reading | 40 | 2013-11-15 | 2018-01-16 |
| Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy Insulin - Diabetes, Gestational, Diabetes, Type 2 | Not applicable | Completed | St. Luke's-Roosevelt Hospital Center | 105 | 2013-03-01 | 2017-05-30 |
| Breakfast Nutrition and Inpatient Glycemia Modified Carbohydrate Breakfast, Control Breakfast - Diabetes, Type 1, Diabetes, Type 2 | Not applicable | Completed | Duke University | 237 | 2012-09-01 | 2015-10-14 |
| The Relationship of Hemoglobin A1c and Diabetic Wound Healing Bacitracin, AmeriGel®, Vitamin C - Diabetes, Type 1, Diabetes, Type 2 | Phase 4 | Terminated | Susan Hassenbein | 2 | 2012-02-01 | 2017-12-12 |
| iDecide.Decido: Diabetes Medication Decision Support Study Community Health Worker Diabetes Education: Print media, CHW Diabetes Education: tailored web site - Diabetes, Type 2 | Not applicable | Completed | University of Michigan | 190 | 2011-09-01 | 2014-09-09 |
| Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes Acarbose, Diet and lifestyle, Metformin - Diabetes, Type 2 | Not applicable | Completed | Services Hospital, Lahore | 161 | 2011-08-01 | 2012-06-20 |
| Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus Placebo, 150 mg PF-04991532, 450 mg PF-04991532 - Diabetes, Type 2 | Phase 2 | Completed | Pfizer | 266 | 2011-06-01 | 2013-08-06 |
| A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes OPC-262 - Diabetes, Type 2 | Phase 3 | Completed | Kyowa Kirin Co., Ltd. | 450 | 2010-07-01 | 2014-01-08 |
| Along-term Study of OPC-262 in Patients With Type 2 Diabetes OPC-262 - Diabetes, Type 2 | Phase 3 | Completed | Kyowa Kirin Co., Ltd. | 222 | 2009-08-01 | 2014-01-08 |
| A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes saxagliptin, placebo - Diabetes, Type 2 | Phase 2 | Completed | Kyowa Kirin Co., Ltd. | 350 | 2009-01-01 | 2017-03-09 |
| Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes Technosphere® Insulin Inhalation Powder, Usual Care - Diabetes, Type 1, Diabetes, Type 2 | Phase 3 | Completed | Mannkind Corporation | 2053 | 2005-06-01 | 2014-10-16 |
| Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 Diabetes Atorvastatin and Omega-3 fatty acids - Diabetes, Type 2 | Phase 4 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 810 | 2004-11-01 | 2021-02-18 |
| A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control Muraglitazar - Diabetes, Type 2 | Phase 3 | Completed | Bristol-Myers Squibb | 341 | 2003-06-01 | 2012-04-27 |
Diabetes Mellitus, Type 2 (19) · Diabetes Mellitus (3) · Diabetes Mellitus, Type 1 (3) · Insulin Resistance (2) · Obesity (2) · Overweight (2) · Body Weight (1) · Cardiovascular Diseases (1) · Diabetes, Gestational (1) · Diabetic Foot (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Hyperglycemia (1) · Hypoglycemia (1) · Metabolic Diseases (1)
Endocrine System Diseases (18) · Glucose Metabolism Disorders (18) · Metabolic Diseases (18) · Nutritional and Metabolic Diseases (18) · Diabetes Mellitus (16) · Autoimmune Diseases (3) · Immune System Diseases (3) · Hyperinsulinism (2) · Body Weight (1) · Cardiovascular Diseases (1) · Diabetes Complications (1) · Diabetic Angiopathies (1) · Diabetic Neuropathies (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Foot Ulcer (1)
Diet (2) · Insulin Glargine (2) · 6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid (1) · Acarbose (1) · Ascorbic Acid (1) · Atorvastatin (1) · Bacitracin (1) · Breakfast (1) · Carbohydrates (1) · Fatty Acids, Omega-3 (1) · Insulin (1) · Insulin, Isophane (1) · Isophane Insulin, Human (1) · Metformin (1) · Sitagliptin Phosphate (1)
Kyowa Kirin Co., Ltd. (3) · Pfizer (2) · Bristol-Myers Squibb (1) · Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète (1) · Duke University (1) · Inova Health Care Services (1) · Mannkind Corporation (1) · Novo Nordisk A/S (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · Services Hospital, Lahore (1) · St. Luke's-Roosevelt Hospital Center (1) · Susan Hassenbein (1) · University of Michigan (1) · University of Reading (1) · West China Hospital (1)
United States (10) · Canada (4) · Japan (4) · Poland (4) · United Kingdom (4) · Spain (3) · Bulgaria (2) · Czechia (2) · Germany (2) · Mexico (2) · Puerto Rico (2) · Slovakia (2) · South Korea (2) · Taiwan (2) · Argentina (1)
Dr Khadija Irfan, MBBS,FCPS (1) · Hyuk-Sang Kwon, MD, PhD (1) · Kathryn J Evans, NP (1) · Katsuhisa Saito (1) · Lillian F Lien, MD (1) · Mai Alhazzaa, Md, PhD (1) · Mark N Feinglos, MD (1) · Michele Heisler, MD (1) · Nell V. Blake, DPM (1) · Stephen C Clement, MD (1) · Xingwu Ran, Doctor (1)
PMID 12020338, PMID 12610053, PMID 12637977, PMID 16140262, PMID 16845794, PMID 16873813, PMID 17240473, PMID 18497454, PMID 18784090, PMID 18784091, PMID 19389816, PMID 19764578, PMID 19900228, PMID 20086313, PMID 20424232, PMID 21169911, PMID 21218511, PMID 21668334, PMID 21854404, PMID 22028279, PMID 23594032, PMID 23757434, PMID 25402398, PMID 26070699, PMID 42168822, PMID 8366922, PMID 9742976
2023 (1), 2025 (1)